Advanced Solid Tumors Harboring KRAS G12C Mutation Clinical Trials

Advanced Solid Tumors Harboring KRAS G12C Mutation

Explore clinical trials studying Advanced Solid Tumors Harboring KRAS G12C Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Advanced Solid Tumors Harboring KRAS G12C Mutation trial results

Recruiting

A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation

NCT06659341

Conditions: Advanced Solid Tumors Harboring KRAS G12C Mutation
Locations: Border Medical oncology - Albury Wodonga Regional Cancer Centre Albury, New South Wales, Australia

Macquarie University Hospital - Oncology Department Macquarie Park, New South Wales, Australia

Peninsula and Southeast Oncology Frankston, Victoria, Australia

Rigshospitalet Copenhagen University Hospital | Oncology Department Copenhagen, Capital Region, Denmark

View Trial Details